GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (STU:6BG) » Definitions » FCF Yield %

Lytix Biopharma AS (STU:6BG) FCF Yield % : -22.06 (As of Apr. 10, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Lytix Biopharma AS's Trailing 12-Month Free Cash Flow is €-6.05 Mil, and Market Cap is €27.95 Mil. Therefore, Lytix Biopharma AS's FCF Yield % for today is -22.06%.

The historical rank and industry rank for Lytix Biopharma AS's FCF Yield % or its related term are showing as below:

STU:6BG' s FCF Yield % Range Over the Past 10 Years
Min: -49.78   Med: -19.48   Max: 33.16
Current: -22.06


During the past 7 years, the highest FCF Yield % of Lytix Biopharma AS was 33.16%. The lowest was -49.78%. And the median was -19.48%.

STU:6BG's FCF Yield % is ranked worse than
54.3% of 1499 companies
in the Biotechnology industry
Industry Median: -16.56 vs STU:6BG: -22.06

Lytix Biopharma AS's FCF Margin % for the quarter that ended in Dec. 2024 was -4,415.63%.


Lytix Biopharma AS FCF Yield % Historical Data

The historical data trend for Lytix Biopharma AS's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lytix Biopharma AS FCF Yield % Chart

Lytix Biopharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial - -8.28 -18.29 -50.80 -18.23

Lytix Biopharma AS Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.14 -33.00 -11.53 -18.22 -17.20

Competitive Comparison of Lytix Biopharma AS's FCF Yield %

For the Biotechnology subindustry, Lytix Biopharma AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lytix Biopharma AS's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lytix Biopharma AS's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Lytix Biopharma AS's FCF Yield % falls into.


;
;

Lytix Biopharma AS FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Lytix Biopharma AS's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-5.99 / 32.852638
=-18.23%

Lytix Biopharma AS's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.413 * 4 / 32.852638
=-17.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lytix Biopharma AS FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Lytix Biopharma AS FCF Yield % Related Terms

Thank you for viewing the detailed overview of Lytix Biopharma AS's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lytix Biopharma AS Business Description

Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401, and LTX-315 are in the pipeline.

Lytix Biopharma AS Headlines

No Headlines